USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2017 | 2016 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | -341.4 Million | -201.5 Million |
Net Income | - | - | - | - | -321 Million | -67.9 Million |
Depreciation & Amortization | - | - | - | - | 31.4 Million | 48.4 Million |
Deferred income taxes | - | - | - | - | 2.8 Million | 5.2 Million |
Stock-based compensation | - | - | - | - | 3.1 Million | -400 Thousand |
Change in working capital | - | - | - | - | -5.6 Million | -76 Million |
Other non-cash items | - | - | - | - | -52.1 Million | -110.8 Million |
Investing Cash Flow | - | - | - | - | 270.7 Million | 258.9 Million |
Investments in PPE | - | - | - | - | -27.4 Million | -45.4 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | 298.1 Million | 304.3 Million |
Financing Cash Flow | - | - | - | - | -5.6 Million | -5.8 Million |
Debt repayment | - | - | - | - | -3.9 Million | -3.9 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | -1.7 Million | -1.9 Million |
Accounts receivables | - | - | - | - | -7.7 Million | 12.5 Million |
Accounts payables | - | - | - | - | -18.6 Million | -35.3 Million |
Inventory | - | - | - | - | 66.3 Million | -23.4 Million |
Other working capital | - | - | - | - | -45.6 Million | -29.8 Million |
Cash at beginning of period | - | - | - | - | 313.9 Million | 259 Million |
Cash at end of period | - | - | - | - | 235.8 Million | 313.9 Million |
Capital Expenditure | - | - | - | - | -27.4 Million | -45.4 Million |
Effect of forex changes on cash | - | - | - | - | -1.8 Million | 3.3 Million |
Net cash flow / Change in cash | - | - | - | - | -78.1 Million | 54.9 Million |
Free Cash Flow | - | - | - | - | -368.8 Million | -246.9 Million |
Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2017 Q1 | 2016 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | -144.4 Million | -321 Million |
Depreciation & Amortization | - | - | - | - | 3.5 Million | 31.4 Million |
Deferred income taxes | - | - | - | - | -800 Thousand | 2.8 Million |
Stock-based compensation | - | - | - | - | 300 Thousand | 3.1 Million |
Change in working capital | - | - | - | - | -82.7 Million | -5.6 Million |
Other non-cash items | - | - | - | - | -11.4 Million | -52.1 Million |
Investing Cash Flow | - | - | - | - | 45.7 Million | 270.7 Million |
Investments in PPE | - | - | - | - | -11.7 Million | -27.4 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | 57.4 Million | 298.1 Million |
Financing Cash Flow | - | - | - | - | 115.4 Million | -5.6 Million |
Debt repayment | - | - | - | - | -900 Thousand | -3.9 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | 116.3 Million | -1.7 Million |
Accounts receivables | - | - | - | - | 5.6 Million | -7.7 Million |
Accounts payables | - | - | - | - | 10 Million | -18.6 Million |
Inventory | - | - | - | - | -59.8 Million | 66.3 Million |
Other working capital | - | - | - | - | -38.5 Million | -45.6 Million |
Cash at beginning of period | - | - | - | - | 235.8 Million | 313.9 Million |
Cash at end of period | - | - | - | - | 164.4 Million | 235.8 Million |
Capital Expenditure | - | - | - | - | -11.7 Million | -27.4 Million |
Effect of forex changes on cash | - | - | - | - | 3 Million | -1.8 Million |
Net cash flow / Change in cash | - | - | - | - | -71.4 Million | -78.1 Million |
Free Cash Flow | - | - | - | - | -247.2 Million | -368.8 Million |
ARCVF
AUTO
TGCB
CVS
3848
DISI